Eagle Pharmaceuticals Inc (EGRX) — Free Cash Flow Generation Index
Eagle Pharmaceuticals Inc (EGRX) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $37.55 Million represents 1% of operating cash flow ($37.56 Million). See Eagle Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Eagle Pharmaceuticals Inc Free Cash Flow Generation Index (2016–2022)
Historical FCF Generation Index trend for Eagle Pharmaceuticals Inc across 7 annual periods. Explore cash flow to debt ratio of Eagle Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Eagle Pharmaceuticals Inc (2016–2022)
Year-by-year Free Cash Flow Generation Index for Eagle Pharmaceuticals Inc. For the full company profile including market capitalisation, see EGRX market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.00x | $30.80 Million | $30.80 Million | $178.00K | ▲ +1.2% |
| 2021 | 0.99x | $27.90 Million | $28.22 Million | $323.00K | ▲ +0.4% |
| 2020 | 0.98x | $48.75 Million | $49.50 Million | $747.00K | ▼ -0.1% |
| 2019 | 0.99x | $55.21 Million | $55.99 Million | $777.00K | ▼ -1.1% |
| 2018 | 1.00x | $52.25 Million | $52.38 Million | $133.00K | ▲ +9.4% |
| 2017 | 0.91x | $53.73 Million | $58.92 Million | $5.19 Million | ▲ +49.2% |
| 2016 | 0.61x | $32.52 Million | $53.21 Million | $20.69 Million | — |